Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05224440 · ClinicalTrials.gov registry record · NA

National Sponsorship Program for Transitioning Service Members

A NA study of Health and Connectedness, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
630
Enrollment target
2
Study locations

NCT05224440 is a NA study of Health and Connectedness that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 630 participants, below the 3,182-participant average among 6 other Health trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05224440, a NA study of Health and Connectedness, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
630 participants
Enrollment target
2
Study locations

Study Summary

Background: The United States is undergoing a suicide epidemic for its youngest Veterans (18-to-34-years-old) as their suicide rate has almost doubled since 2001. Veterans are at the highest risk during their first-year post-discharge, thus creating a "deadly gap" for them. In response, the nation has developed strategies that emphasize a preventive, universal and public health approach and embrace the value of community interventions. The three-step theory of suicide suggests that community interventions that reduce pain from reintegration difficulties and promote connectedness for Veterans as they transition to civilian life have the greatest likelihood of success. Recent research shows that the effectiveness of community interventions can be enhanced when augmented by volunteer and certified sponsors (1-on-1) who actively engage with Veterans, as part of the Veterans Affairs' Transitioning Servicemember/Veteran (TSMV) Sponsorship Initiative. Method/Design: The purpose of this trial is to determine how to implement the Veteran Sponsorship Initiative in six cities in Texas in collaboration with the US Department of Defense, VA, Texas government, and local stakeholders. Texas is an optimal location for this large-scale implementation as it has the second largest population of Veterans aged 18-to-34-years-old and is home to the largest US military installation, Fort Hood. The first aim is to further determine the effectiveness of the Sponsorship Initiative, as evidenced by measures of proximal variables (reintegration difficulties, health/psychological distress, VA healthcare utilization and connectedness) and distal variables (suicidal ideation and behaviors). The second aim is to determine how best to implement the Veteran Sponsorship Initiative in Texas with the intent of future expansion in more states. TSMVs (n=630) will be recruited from military installations six months prior to discharge and prior to moving to target cities. The evaluators are utilizing im

Interventions

  • BEHAVIORAL Veteran Sponsorship Initiative

Study Locations (2)

New York

  • James J. Peters VA Medical Center, Bronx, NY - The Bronx

Texas

  • Central Texas Veterans Health Care System Waco VA Medical Center, Waco, TX - Waco

Trial Details

FieldValue
Enrollment Target 630 participants
Start Date 2022-02-04
Est. Completion 2026-09-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05224440

The ClinicalTrials.gov registry entry for NCT05224440 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 630 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,182-participant average among 6 other Health trials with a reported enrollment target (80% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Health appearing as the primary indexed condition, and to 1 intervention - of which Veteran Sponsorship Initiative is the first listed.

NCT05224440 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Texas.

Frequently Asked Questions

What is clinical trial NCT05224440 about?

NCT05224440 is a clinical study titled "National Sponsorship Program for Transitioning Service Members". Background: The United States is undergoing a suicide epidemic for its youngest Veterans (18-to-34-years-old) as their suicide rate has almost doubled since 2001. Veterans are at the highest risk during their first-year post-discharge, thus creating a "deadly gap" for them. In response, the nation ...

What is the current status of trial NCT05224440?

This trial is currently recruiting. It is a NA study. The enrollment target is 630 participants. The study started on 2022-02-04. Estimated completion is 2026-09-30.

What conditions does trial NCT05224440 study?

This clinical trial studies the following conditions: Health, Connectedness, Reintegration Difficulties, Suicidal Ideation and Behaviors.

What interventions are being tested in trial NCT05224440?

The interventions under investigation include: Veteran Sponsorship Initiative (BEHAVIORAL).

Who is sponsoring clinical trial NCT05224440?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05224440 being conducted?

This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.